190 related articles for article (PubMed ID: 25072176)
1. Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma.
Sylvester KG; Colnot S
Gastroenterology; 2014 Sep; 147(3):562-5. PubMed ID: 25072176
[No Abstract] [Full Text] [Related]
2. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
3. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
[TBL] [Abstract][Full Text] [Related]
4. Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.
Park J; Jeong S
Oncotarget; 2015 Oct; 6(33):34658-68. PubMed ID: 26415221
[TBL] [Abstract][Full Text] [Related]
5. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.
Oudhoff MJ; Braam MJS; Freeman SA; Wong D; Rattray DG; Wang J; Antignano F; Snyder K; Refaeli I; Hughes MR; McNagny KM; Gold MR; Arrowsmith CH; Sato T; Rossi FMV; Tatlock JH; Owen DR; Brown PJ; Zaph C
Dev Cell; 2016 Apr; 37(1):47-57. PubMed ID: 27046831
[TBL] [Abstract][Full Text] [Related]
6. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
[TBL] [Abstract][Full Text] [Related]
7. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu MM; Gagea M; Cote G
Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.
Cai J; Maitra A; Anders RA; Taketo MM; Pan D
Genes Dev; 2015 Jul; 29(14):1493-506. PubMed ID: 26193883
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
10. YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte-Like Cells.
Smith JL; Rodríguez TC; Mou H; Kwan SY; Pratt H; Zhang XO; Cao Y; Liang S; Ozata DM; Yu T; Yin Q; Hazeltine M; Weng Z; Sontheimer EJ; Xue W
Hepatology; 2021 Mar; 73(3):1011-1027. PubMed ID: 32452550
[TBL] [Abstract][Full Text] [Related]
11. YAP-mediated induction of monoacylglycerol lipase restrains oncogenic transformation.
Tang ED; Wang CY
Cell Signal; 2015 Apr; 27(4):836-40. PubMed ID: 25636199
[TBL] [Abstract][Full Text] [Related]
12. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells.
Perumal N; Perumal M; Kannan A; Subramani K; Halagowder D; Sivasithamparam N
Exp Cell Res; 2017 Jun; 355(2):124-141. PubMed ID: 28366538
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
[TBL] [Abstract][Full Text] [Related]
14. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.
Rosenbluh J; Nijhawan D; Cox AG; Li X; Neal JT; Schafer EJ; Zack TI; Wang X; Tsherniak A; Schinzel AC; Shao DD; Schumacher SE; Weir BA; Vazquez F; Cowley GS; Root DE; Mesirov JP; Beroukhim R; Kuo CJ; Goessling W; Hahn WC
Cell; 2012 Dec; 151(7):1457-73. PubMed ID: 23245941
[TBL] [Abstract][Full Text] [Related]
16. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
[TBL] [Abstract][Full Text] [Related]
17. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
[TBL] [Abstract][Full Text] [Related]
18. Muscle Yap Is a Regulator of Neuromuscular Junction Formation and Regeneration.
Zhao K; Shen C; Lu Y; Huang Z; Li L; Rand CD; Pan J; Sun XD; Tan Z; Wang H; Xing G; Cao Y; Hu G; Zhou J; Xiong WC; Mei L
J Neurosci; 2017 Mar; 37(13):3465-3477. PubMed ID: 28213440
[TBL] [Abstract][Full Text] [Related]
19. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
20. WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.
Gargini R; Escoll M; García E; García-Escudero R; Wandosell F; Antón IM
Cell Rep; 2016 Nov; 17(8):1962-1977. PubMed ID: 27851961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
